Celltrion, 328,331 Shares Net Sold by Individuals Over Last 5 Days... Stock Price at 305,000 Won (-1.13%)

As of 11:31 AM on the 14th, Celltrion is trading at 305,000 KRW, down 1.13% from the previous day. The trading volume is 629,994 shares, which is about 36.38% of the previous day's volume. Celltrion is known as a protein and biopharmaceutical manufacturing company.

On August 11, Choi Jong-kyung, a researcher at Heungkuk Securities, stated, "Truxima has secured a 16.4% market share in the U.S. market, showing a steep upward trend. In the European market, existing products are steadily maintaining their market share. Remsima SC, launched in February 2020, has not yet generated significant sales in the market but is being pre-supplied with quantities considered as safety stock. In July, all adult indications were approved, and it is expected to be actively sold in the market. The plan to build the third plant in Songdo, Incheon, is still under discussion with the Incheon city authorities." He set Celltrion's target price at 400,000 KRW.

Over the past five days, individual investors have net sold 328,331 shares of Celltrion, while foreigners and institutions have net bought 247,785 shares and 75,968 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.